Hospital Infection Therapeutics Market 2025 to 2034
Hospital Infection Therapeutics Market 2025 to 2034
Hospital Infection Therapeutics Market (By Drug Type: Antibiotics Drugs, Antifungal Drugs, Antiviral Drugs, Others; By Applications: Bloodstream Infections, Pneumonia, Surgical Site Infections, Urinary Tract Infections, Gastrointestinal Disorders, Other Hospital Infections; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2024
USD 12.82 Bn
Forecast Year, 2034
USD 16.59 Bn
CAGR, 2025 - 2034
2.9
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global hospital infection therapeutics market, valued at USD 12.82 billion in 2025, is projected to reach USD 16.59 billion by 2034, growing at a CAGR of 2.9%, driven by rising hospital-acquired infections and the demand for advanced treatment solutions.
Hospital Infection Therapeutics Market Size Analysis
Hospital Infection Therapeutics Market Size By Drug Type 2025 to 2034 (USD Billion)
| Drug Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics Drugs | 1.29 | 1.32 | 1.37 | 1.40 | 1.46 | 1.47 | 1.53 | 1.57 | 1.63 | 1.65 |
| Antifungal Drugs | 2.58 | 2.64 | 2.72 | 2.79 | 2.87 | 2.96 | 3.05 | 3.13 | 3.23 | 3.34 |
| Antiviral Drugs | 3.83 | 3.97 | 4.07 | 4.18 | 4.30 | 4.44 | 4.56 | 4.69 | 4.82 | 4.98 |
| Others | 5.13 | 5.27 | 5.41 | 5.59 | 5.75 | 5.91 | 6.08 | 6.27 | 6.43 | 6.61 |
Hospital Infection Therapeutics Market Size By Applications 2025 to 2034 (USD Billion)
| Applications | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bloodstream Infections | 0.61 | 0.63 | 0.65 | 0.67 | 0.69 | 0.72 | 0.72 | 0.75 | 0.78 | 0.79 |
| Pneumonia | 1.23 | 1.26 | 1.30 | 1.33 | 1.37 | 1.41 | 1.46 | 1.49 | 1.54 | 1.58 |
| Surgical Site Infections | 1.84 | 1.89 | 1.93 | 2.00 | 2.06 | 2.11 | 2.18 | 2.24 | 2.30 | 2.37 |
| Urinary Tract Infections | 2.44 | 2.51 | 2.59 | 2.66 | 2.74 | 2.81 | 2.90 | 2.99 | 3.07 | 3.16 |
| Gastrointestinal Disorders | 3.05 | 3.14 | 3.23 | 3.32 | 3.41 | 3.52 | 3.62 | 3.73 | 3.83 | 3.95 |
| Other Hospital Infections | 3.66 | 3.76 | 3.87 | 3.98 | 4.10 | 4.22 | 4.34 | 4.46 | 4.60 | 4.73 |
Hospital Infection Therapeutics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.28 | 1.32 | 1.36 | 1.40 | 1.45 | 1.50 | 1.54 | 1.58 | 1.60 | 1.68 |
| LAMEA | 2.57 | 2.64 | 2.71 | 2.79 | 2.88 | 2.96 | 3.05 | 3.14 | 3.24 | 3.31 |
| Europe | 3.85 | 3.95 | 4.07 | 4.20 | 4.31 | 4.43 | 4.55 | 4.69 | 4.83 | 4.97 |
| Asia-Pacific | 5.12 | 5.28 | 5.43 | 5.58 | 5.74 | 5.90 | 6.08 | 6.26 | 6.44 | 6.63 |
Hospital Infection Therapeutics Market Size to Hit USD 16.59 Billion by 2034
The global hospital infection therapeutics market size is calculated at USD 12.82 billion in 2025 and is predicted to attain around USD 16.59 billion by 2034 with a expanding at a CAGR of 2.9%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
